CIK 0000890821 · Non-accelerated filer<br>Smaller reporting company
Enveric Biosciences, Inc.
Sign in to watch- Ticker
- ENVB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 954484725
- Phone
- (617) 444-8400
- Business address
- 245 FIRST STREET RIVERVIEW II 18TH FLOOR, CAMBRIDGE, MA, 02142
- Former names
- AMERI Holdings, Inc., SPATIALIZER AUDIO LABORATORIES INC
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Material agreement · Acquisition or sale completed · Unregistered share sale
- 8-K Event Material agreement · Unregistered share sale
- UPLOAD Other SEC-generated Letter
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 434 shares at $6.51 ($2,825)
- S-1 Offering Registration Statement
- 4 Option exercise Director acquired 17,663 shares (option exercise)
- 4 Option exercise Director acquired 14,245 shares (option exercise)
- 4 Option exercise Director acquired 16,809 shares (option exercise)
- 4 Option exercise Director acquired 14,245 shares (option exercise)
- 4 Open-market buy Director bought 2,130 shares at $6.51 ($13,866)
- 4 Open-market buy Director bought 10,000 shares at $6.51 ($65,100)
- 4 Open-market buy Director bought 40 shares at $6.51 ($260)
- SC 13D/A Stake Beneficial Ownership Report
- 8-K Event Material agreement · Unregistered share sale · Shareholder rights changed · Bylaws or fiscal year change
- 4 Open-market buy Director bought 1,506 shares at $6.51 ($9,804)
- 4 Open-market buy Director bought 700 shares at $6.51 ($4,557)
- 8-K Event Executive or director change
- 4 Open-market buy Director bought 808 shares at $6.51 ($5,260)
Page 35 of 53 · 1,057 filings